Jefferies Upgrades Team Health (TMH) to Buy

August 11, 2016 7:10 AM EDT
Get Alerts TMH Hot Sheet
Price: $43.41 +0.02%

Rating Summary:
    4 Buy, 14 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade TMH Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Jefferies upgraded Team Health (NYSE: TMH) from Hold to Buy with a price target of $47.00 (from $49.00).

Analyst Brian Tanquilut commented, "Upgrading TMH to Buy given our belief that investor expectations, along with the stock's valuation, have hit trough levels. While we recognize that stock upside hinges on mgmt. execution, any progress with the IPCM integration or the realization of BPCI revenues, in our view, should drive earnings upside and re-ignite positive stock momentum. We also expect TMH to be a beneficiary of MACRA-driven consolidation given its aggressive M&A strategy."

The firm lowered FY 2016 EPS from $2.89 to $2.73 and FY 2017 EPS from $3.29 to $3.13.

For an analyst ratings summary and ratings history on Team Health click here. For more ratings news on Team Health click here.

Shares of Team Health closed at $36.04 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change, Upgrades

Related Entities

Jefferies & Co, Earnings

Add Your Comment